Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cxxc1
|
ENSMUSG00000024560.6 | CXXC finger 1 (PHD domain) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr18_74215667_74215968 | Cxxc1 | 307 | 0.875769 | 0.67 | 3.6e-09 | Click! |
chr18_74216226_74217021 | Cxxc1 | 492 | 0.762225 | 0.43 | 6.3e-04 | Click! |
chr18_74218699_74218850 | Cxxc1 | 67 | 0.967382 | -0.30 | 2.1e-02 | Click! |
chr18_74217821_74218105 | Cxxc1 | 92 | 0.962884 | -0.18 | 1.8e-01 | Click! |
chr18_74218537_74218688 | Cxxc1 | 229 | 0.915258 | -0.07 | 5.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_58156326_58158409 | 4.81 |
Islr |
immunoglobulin superfamily containing leucine-rich repeat |
1178 |
0.35 |
chr8_45658542_45659771 | 3.73 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
352 |
0.89 |
chr7_123983249_123983725 | 3.39 |
Gm27040 |
predicted gene, 27040 |
33 |
0.92 |
chr5_119834833_119836185 | 3.01 |
Tbx5 |
T-box 5 |
646 |
0.68 |
chr5_142960410_142961450 | 2.77 |
Fscn1 |
fascin actin-bundling protein 1 |
87 |
0.97 |
chr10_23348425_23349045 | 2.74 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
1152 |
0.64 |
chr15_37905683_37906241 | 2.58 |
Gm35019 |
predicted gene, 35019 |
6246 |
0.16 |
chr7_37624005_37624468 | 2.58 |
Gm44883 |
predicted gene 44883 |
38402 |
0.15 |
chr3_141466933_141467846 | 2.54 |
Unc5c |
unc-5 netrin receptor C |
1718 |
0.37 |
chr7_82335360_82336568 | 2.44 |
Adamtsl3 |
ADAMTS-like 3 |
232 |
0.93 |
chr3_8663653_8664237 | 2.44 |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
2680 |
0.2 |
chr1_106712574_106713226 | 2.43 |
Bcl2 |
B cell leukemia/lymphoma 2 |
279 |
0.92 |
chr16_77593904_77594384 | 2.28 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
222 |
0.87 |
chr5_81019732_81019945 | 2.27 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
300 |
0.95 |
chr2_181680341_181681005 | 2.26 |
Tcea2 |
transcription elongation factor A (SII), 2 |
363 |
0.74 |
chr3_45379351_45381850 | 2.26 |
Pcdh10 |
protocadherin 10 |
2033 |
0.25 |
chr11_3330811_3331731 | 2.25 |
Gm12592 |
predicted gene 12592 |
93 |
0.84 |
chr3_98382464_98383382 | 2.20 |
Zfp697 |
zinc finger protein 697 |
375 |
0.85 |
chr2_106694955_106695411 | 2.18 |
Mpped2 |
metallophosphoesterase domain containing 2 |
37 |
0.98 |
chr6_124768623_124769473 | 2.16 |
Eno2 |
enolase 2, gamma neuronal |
436 |
0.57 |
chr17_32506446_32507126 | 2.15 |
Cyp4f17 |
cytochrome P450, family 4, subfamily f, polypeptide 17 |
268 |
0.87 |
chr18_9214278_9214931 | 2.15 |
Fzd8 |
frizzled class receptor 8 |
2441 |
0.35 |
chr16_5306842_5307937 | 2.14 |
Gm41414 |
predicted gene, 41414 |
588 |
0.68 |
chr9_58311848_58313176 | 2.13 |
Loxl1 |
lysyl oxidase-like 1 |
674 |
0.66 |
chr2_91035627_91036540 | 2.13 |
Rapsn |
receptor-associated protein of the synapse |
442 |
0.7 |
chr17_8801784_8802345 | 2.13 |
Pde10a |
phosphodiesterase 10A |
285 |
0.93 |
chr7_16810738_16811990 | 2.12 |
Fkrp |
fukutin related protein |
4157 |
0.12 |
chr6_53819040_53819677 | 2.12 |
Gm16499 |
predicted gene 16499 |
615 |
0.65 |
chr12_77949549_77950297 | 2.05 |
Gm8219 |
predicted gene 8219 |
130341 |
0.05 |
chr17_49562986_49564570 | 2.03 |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
528 |
0.84 |
chr3_38886705_38888202 | 2.01 |
Fat4 |
FAT atypical cadherin 4 |
513 |
0.62 |
chr13_112288146_112289061 | 2.00 |
Ankrd55 |
ankyrin repeat domain 55 |
14 |
0.97 |
chr2_125660207_125661230 | 2.00 |
Eid1 |
EP300 interacting inhibitor of differentiation 1 |
12377 |
0.18 |
chr9_50723262_50723600 | 1.96 |
Dixdc1 |
DIX domain containing 1 |
4507 |
0.13 |
chr2_148441004_148443557 | 1.96 |
Cd93 |
CD93 antigen |
1283 |
0.41 |
chr5_72647177_72647701 | 1.96 |
Nipal1 |
NIPA-like domain containing 1 |
356 |
0.78 |
chr3_54154932_54155429 | 1.95 |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
855 |
0.72 |
chr15_11036089_11037859 | 1.95 |
Rxfp3 |
relaxin family peptide receptor 3 |
1017 |
0.52 |
chr18_36286468_36286908 | 1.90 |
Pura |
purine rich element binding protein A |
5591 |
0.2 |
chr3_97768088_97768407 | 1.89 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
238 |
0.93 |
chr12_76821715_76823013 | 1.85 |
Rab15 |
RAB15, member RAS oncogene family |
98 |
0.96 |
chr11_65269494_65270784 | 1.84 |
Myocd |
myocardin |
150 |
0.96 |
chr8_88453768_88454741 | 1.84 |
Gm45497 |
predicted gene 45497 |
63133 |
0.1 |
chr18_47367607_47368430 | 1.84 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
250 |
0.93 |
chr15_78428616_78429010 | 1.83 |
Kctd17 |
potassium channel tetramerisation domain containing 17 |
17 |
0.95 |
chr14_36918744_36919600 | 1.83 |
Ccser2 |
coiled-coil serine rich 2 |
161 |
0.97 |
chr5_119803355_119804193 | 1.83 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
3893 |
0.21 |
chr5_36868265_36868545 | 1.83 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
108 |
0.96 |
chr11_5802324_5803834 | 1.82 |
Pgam2 |
phosphoglycerate mutase 2 |
654 |
0.56 |
chr3_137777915_137778294 | 1.81 |
Mir6380 |
microRNA 6380 |
5511 |
0.16 |
chr7_62348312_62349429 | 1.81 |
Ndn |
necdin |
2301 |
0.3 |
chr4_100095808_100096274 | 1.80 |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
250 |
0.93 |
chr12_110737435_110737787 | 1.79 |
Wdr20 |
WD repeat domain 20 |
333 |
0.85 |
chr8_107545084_107547731 | 1.79 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chr3_94363290_94364465 | 1.78 |
C2cd4d |
C2 calcium-dependent domain containing 4D |
1374 |
0.19 |
chr17_83613932_83614199 | 1.77 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
17830 |
0.23 |
chr6_122741558_122742751 | 1.77 |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
108 |
0.95 |
chr3_101162785_101162991 | 1.75 |
Gm12486 |
predicted gene 12486 |
44511 |
0.11 |
chr14_54991806_54993467 | 1.75 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1055 |
0.25 |
chr13_113616748_113617254 | 1.75 |
Snx18 |
sorting nexin 18 |
1563 |
0.37 |
chr5_88887238_88887864 | 1.74 |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
252 |
0.94 |
chr15_45114048_45115133 | 1.74 |
Kcnv1 |
potassium channel, subfamily V, member 1 |
237 |
0.95 |
chr14_58073809_58074297 | 1.73 |
Fgf9 |
fibroblast growth factor 9 |
1062 |
0.51 |
chr6_115990456_115990924 | 1.73 |
Plxnd1 |
plexin D1 |
4315 |
0.18 |
chr6_105676979_105678296 | 1.73 |
Cntn4 |
contactin 4 |
23 |
0.52 |
chr1_189342678_189343152 | 1.72 |
Kcnk2 |
potassium channel, subfamily K, member 2 |
440 |
0.52 |
chr12_101816639_101817129 | 1.72 |
Fbln5 |
fibulin 5 |
1584 |
0.4 |
chr18_53861621_53861951 | 1.72 |
Csnk1g3 |
casein kinase 1, gamma 3 |
336 |
0.93 |
chr3_66219854_66220300 | 1.72 |
Ptx3 |
pentraxin related gene |
167 |
0.95 |
chr13_28949369_28949858 | 1.71 |
Sox4 |
SRY (sex determining region Y)-box 4 |
4100 |
0.25 |
chr10_7867001_7868018 | 1.70 |
Gm24726 |
predicted gene, 24726 |
19028 |
0.13 |
chr12_83687826_83688219 | 1.70 |
Psen1 |
presenilin 1 |
130 |
0.94 |
chr13_73604051_73604794 | 1.69 |
Clptm1l |
CLPTM1-like |
416 |
0.83 |
chr6_6015633_6015988 | 1.69 |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
9744 |
0.24 |
chr18_37807794_37808997 | 1.69 |
BC037039 |
cDNA sequence BC037039 |
473 |
0.52 |
chr7_49974833_49976024 | 1.67 |
Nell1 |
NEL-like 1 |
94 |
0.98 |
chr1_160351861_160352416 | 1.66 |
Rabgap1l |
RAB GTPase activating protein 1-like |
567 |
0.73 |
chr14_24003644_24004258 | 1.65 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
21 |
0.59 |
chr8_46208542_46209617 | 1.65 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
1951 |
0.2 |
chr2_71629066_71629667 | 1.65 |
Dlx2 |
distal-less homeobox 2 |
82612 |
0.06 |
chr14_70890801_70891115 | 1.65 |
Gfra2 |
glial cell line derived neurotrophic factor family receptor alpha 2 |
430 |
0.87 |
chrX_150588358_150588734 | 1.64 |
Pfkfb1 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
290 |
0.58 |
chr7_130935568_130935719 | 1.64 |
Htra1 |
HtrA serine peptidase 1 |
468 |
0.8 |
chr1_37889842_37890343 | 1.63 |
Mitd1 |
MIT, microtubule interacting and transport, domain containing 1 |
184 |
0.7 |
chr3_79885722_79887545 | 1.63 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr19_10041589_10042653 | 1.63 |
Fads3 |
fatty acid desaturase 3 |
389 |
0.78 |
chr10_40024345_40025318 | 1.62 |
Mfsd4b1 |
major facilitator superfamily domain containing 4B1 |
328 |
0.82 |
chr6_145933944_145934978 | 1.61 |
Sspn |
sarcospan |
339 |
0.86 |
chr8_72443952_72444140 | 1.61 |
1700030K09Rik |
RIKEN cDNA 1700030K09 gene |
114 |
0.57 |
chr5_101663336_101663763 | 1.60 |
Nkx6-1 |
NK6 homeobox 1 |
1447 |
0.41 |
chr13_18948071_18948332 | 1.60 |
Amph |
amphiphysin |
4 |
0.97 |
chrX_99002913_99003771 | 1.60 |
Stard8 |
START domain containing 8 |
94 |
0.97 |
chr4_55530048_55530420 | 1.59 |
Klf4 |
Kruppel-like factor 4 (gut) |
1536 |
0.35 |
chr4_54757935_54758744 | 1.59 |
Gm12477 |
predicted gene 12477 |
88147 |
0.07 |
chr16_35155941_35156382 | 1.59 |
Adcy5 |
adenylate cyclase 5 |
1284 |
0.52 |
chr10_58813731_58814024 | 1.58 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
182 |
0.87 |
chr10_82178709_82179097 | 1.58 |
Gm15608 |
predicted gene 15608 |
531 |
0.69 |
chr2_146810521_146810941 | 1.58 |
Gm14114 |
predicted gene 14114 |
29001 |
0.18 |
chr18_10786308_10786708 | 1.58 |
Mir133a-1hg |
Mir133a-1, Mir1b and Mir1a-2 host gene |
625 |
0.41 |
chr3_151836690_151837893 | 1.58 |
Ptgfr |
prostaglandin F receptor |
339 |
0.74 |
chr2_165992333_165992538 | 1.57 |
Gm11464 |
predicted gene 11464 |
82 |
0.66 |
chr19_42201012_42202482 | 1.56 |
Sfrp5 |
secreted frizzled-related sequence protein 5 |
505 |
0.71 |
chr9_56924258_56925637 | 1.56 |
Snx33 |
sorting nexin 33 |
3424 |
0.13 |
chr17_69969717_69970050 | 1.56 |
Dlgap1 |
DLG associated protein 1 |
462 |
0.86 |
chr16_17833135_17833286 | 1.56 |
B830017H08Rik |
RIKEN cDNA B830017H08 gene |
89 |
0.93 |
chr4_133040034_133040455 | 1.55 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
751 |
0.67 |
chr5_123508032_123508356 | 1.55 |
Gm15751 |
predicted gene 15751 |
201 |
0.84 |
chr17_37196656_37197851 | 1.55 |
Olfr94 |
olfactory receptor 94 |
758 |
0.35 |
chr11_43835659_43836527 | 1.54 |
Adra1b |
adrenergic receptor, alpha 1b |
239 |
0.95 |
chr10_73099097_73100287 | 1.53 |
Pcdh15 |
protocadherin 15 |
239 |
0.94 |
chr2_168281185_168281601 | 1.53 |
Kcng1 |
potassium voltage-gated channel, subfamily G, member 1 |
261 |
0.88 |
chr18_52768404_52769104 | 1.53 |
Sncaip |
synuclein, alpha interacting protein (synphilin) |
22 |
0.98 |
chr15_101845441_101846125 | 1.53 |
Krt1 |
keratin 1 |
811 |
0.44 |
chr5_69340481_69341683 | 1.52 |
Gm24368 |
predicted gene, 24368 |
299 |
0.7 |
chr17_38991085_38991236 | 1.52 |
Gm49826 |
predicted gene, 49826 |
38425 |
0.1 |
chr8_84004085_84004783 | 1.51 |
Mir8111 |
microRNA 8111 |
1194 |
0.21 |
chr11_6527849_6528713 | 1.51 |
Snora9 |
small nucleolar RNA, H/ACA box 9 |
116 |
0.81 |
chr7_130258773_130259779 | 1.50 |
Fgfr2 |
fibroblast growth factor receptor 2 |
2581 |
0.38 |
chr9_44361744_44361968 | 1.50 |
Vps11 |
VPS11, CORVET/HOPS core subunit |
186 |
0.81 |
chr10_78787171_78788340 | 1.50 |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
7053 |
0.14 |
chr5_35279136_35280046 | 1.49 |
Adra2c |
adrenergic receptor, alpha 2c |
1272 |
0.51 |
chr7_64392759_64393167 | 1.49 |
Mcee |
methylmalonyl CoA epimerase |
188 |
0.84 |
chr10_32889495_32890861 | 1.49 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
283 |
0.94 |
chr15_11399852_11400105 | 1.49 |
Tars |
threonyl-tRNA synthetase |
313 |
0.93 |
chr3_84189998_84191469 | 1.49 |
Trim2 |
tripartite motif-containing 2 |
210 |
0.94 |
chr17_24488403_24488701 | 1.48 |
Caskin1 |
CASK interacting protein 1 |
49 |
0.92 |
chr9_14859896_14860824 | 1.48 |
Gpr83 |
G protein-coupled receptor 83 |
106 |
0.94 |
chr8_85701022_85701259 | 1.48 |
Neto2 |
neuropilin (NRP) and tolloid (TLL)-like 2 |
216 |
0.51 |
chr10_118676040_118676569 | 1.48 |
Gm33337 |
predicted gene, 33337 |
39422 |
0.14 |
chr5_121619059_121619729 | 1.48 |
Acad12 |
acyl-Coenzyme A dehydrogenase family, member 12 |
456 |
0.7 |
chr5_44798248_44798923 | 1.47 |
Ldb2 |
LIM domain binding 2 |
1017 |
0.53 |
chr13_18124371_18124589 | 1.47 |
4930448F12Rik |
RIKEN cDNA 4930448F12 gene |
24278 |
0.14 |
chr4_139575034_139575824 | 1.46 |
Iffo2 |
intermediate filament family orphan 2 |
709 |
0.62 |
chr10_110921543_110922443 | 1.46 |
Csrp2 |
cysteine and glycine-rich protein 2 |
1788 |
0.28 |
chr18_12333542_12334782 | 1.46 |
Lama3 |
laminin, alpha 3 |
343 |
0.87 |
chr14_20082520_20083094 | 1.45 |
Saysd1 |
SAYSVFN motif domain containing 1 |
376 |
0.86 |
chr10_85388315_85388470 | 1.45 |
Btbd11 |
BTB (POZ) domain containing 11 |
1565 |
0.43 |
chr6_6880959_6882181 | 1.45 |
Dlx5 |
distal-less homeobox 5 |
498 |
0.71 |
chr5_150259014_150260303 | 1.45 |
Fry |
FRY microtubule binding protein |
109 |
0.97 |
chr10_81070153_81070659 | 1.44 |
Thop1 |
thimet oligopeptidase 1 |
247 |
0.82 |
chr4_47208070_47209133 | 1.44 |
Gm12426 |
predicted gene 12426 |
142 |
0.81 |
chr8_121651047_121652249 | 1.44 |
Zcchc14 |
zinc finger, CCHC domain containing 14 |
1253 |
0.31 |
chr7_70067726_70068588 | 1.44 |
Gm24120 |
predicted gene, 24120 |
110253 |
0.06 |
chrX_20290867_20291587 | 1.44 |
Slc9a7 |
solute carrier family 9 (sodium/hydrogen exchanger), member 7 |
543 |
0.77 |
chr3_79287473_79287866 | 1.43 |
6430573P05Rik |
RIKEN cDNA 6430573P05 gene |
59 |
0.96 |
chr1_167929561_167930462 | 1.43 |
Gm20711 |
predicted gene 20711 |
74128 |
0.12 |
chr19_24871068_24871435 | 1.43 |
Gm10053 |
predicted gene 10053 |
4435 |
0.16 |
chr2_118113734_118115108 | 1.43 |
Thbs1 |
thrombospondin 1 |
2545 |
0.2 |
chr11_87638819_87639569 | 1.43 |
Hsf5 |
heat shock transcription factor family member 5 |
22030 |
0.11 |
chr8_3475706_3476566 | 1.43 |
Tex45 |
testis expressed 45 |
287 |
0.83 |
chr3_57574188_57574469 | 1.42 |
Wwtr1 |
WW domain containing transcription regulator 1 |
1500 |
0.35 |
chr8_25521556_25521707 | 1.42 |
Fgfr1 |
fibroblast growth factor receptor 1 |
1794 |
0.24 |
chr5_127243036_127243658 | 1.42 |
Tmem132c |
transmembrane protein 132C |
1521 |
0.4 |
chr5_37823264_37824531 | 1.42 |
Msx1 |
msh homeobox 1 |
685 |
0.71 |
chr11_3863097_3863878 | 1.42 |
Osbp2 |
oxysterol binding protein 2 |
416 |
0.76 |
chr8_111145722_111146026 | 1.41 |
9430091E24Rik |
RIKEN cDNA 9430091E24 gene |
394 |
0.8 |
chr14_25902691_25903210 | 1.41 |
Plac9a |
placenta specific 9a |
150 |
0.93 |
chr17_21962538_21963018 | 1.41 |
Zfp943 |
zinc finger prtoein 943 |
192 |
0.62 |
chr14_26042467_26042978 | 1.40 |
Gm9780 |
predicted gene 9780 |
11 |
0.96 |
chr7_143740336_143740649 | 1.40 |
Osbpl5 |
oxysterol binding protein-like 5 |
151 |
0.93 |
chr17_65528505_65529038 | 1.40 |
Tmem232 |
transmembrane protein 232 |
11542 |
0.14 |
chr12_110858726_110858959 | 1.40 |
Mpc1-ps |
mitochondrial pyruvate carrier 1, pseudogene |
52 |
0.94 |
chr5_76856634_76858112 | 1.40 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
1469 |
0.39 |
chr14_3948807_3949490 | 1.39 |
Gm3095 |
predicted gene 3095 |
14399 |
0.11 |
chr14_115017862_115018104 | 1.39 |
Mir17hg |
Mir17 host gene (non-protein coding) |
24896 |
0.09 |
chr6_5725575_5726689 | 1.39 |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
314 |
0.94 |
chr4_147936037_147936691 | 1.39 |
Plod1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
344 |
0.78 |
chr3_55461381_55462661 | 1.39 |
Dclk1 |
doublecortin-like kinase 1 |
49 |
0.97 |
chr6_85373595_85374585 | 1.38 |
Rab11fip5 |
RAB11 family interacting protein 5 (class I) |
474 |
0.76 |
chr10_128459318_128459651 | 1.37 |
Smarcc2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 |
163 |
0.82 |
chr3_26333372_26333954 | 1.37 |
Nlgn1 |
neuroligin 1 |
1203 |
0.44 |
chr5_72867596_72868437 | 1.37 |
Tec |
tec protein tyrosine kinase |
380 |
0.84 |
chr15_59618676_59618957 | 1.37 |
Gm36677 |
predicted gene, 36677 |
226 |
0.94 |
chr2_74668550_74669141 | 1.37 |
Hoxd13 |
homeobox D13 |
535 |
0.48 |
chr3_57294992_57295338 | 1.36 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
40 |
0.98 |
chr15_101369727_101370136 | 1.36 |
Krt80 |
keratin 80 |
231 |
0.72 |
chr12_108994587_108994849 | 1.36 |
Gm18405 |
predicted gene, 18405 |
3067 |
0.2 |
chr11_108923092_108924343 | 1.35 |
Axin2 |
axin 2 |
536 |
0.8 |
chr12_70346335_70347339 | 1.35 |
Trim9 |
tripartite motif-containing 9 |
252 |
0.78 |
chr1_76276224_76276476 | 1.35 |
Gm29069 |
predicted gene 29069 |
144342 |
0.04 |
chr8_83772585_83773188 | 1.35 |
Gm45778 |
predicted gene 45778 |
23382 |
0.12 |
chr18_21651446_21652417 | 1.34 |
4930426D05Rik |
RIKEN cDNA 4930426D05 gene |
366 |
0.55 |
chr5_13399048_13399647 | 1.34 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
23 |
0.99 |
chr2_158228784_158229857 | 1.34 |
D630003M21Rik |
RIKEN cDNA D630003M21 gene |
98 |
0.95 |
chr1_91351519_91351937 | 1.33 |
Klhl30 |
kelch-like 30 |
712 |
0.52 |
chr15_76457174_76458724 | 1.33 |
Scx |
scleraxis |
429 |
0.62 |
chr11_78037959_78038865 | 1.33 |
Flot2 |
flotillin 2 |
428 |
0.67 |
chr16_17070217_17070927 | 1.33 |
Ypel1 |
yippee like 1 |
268 |
0.81 |
chr19_45301076_45301227 | 1.33 |
Gm28578 |
predicted gene 28578 |
2186 |
0.28 |
chr18_44811780_44813059 | 1.33 |
Mcc |
mutated in colorectal cancers |
237 |
0.91 |
chr14_70176049_70177537 | 1.33 |
Pdlim2 |
PDZ and LIM domain 2 |
26 |
0.96 |
chr18_80360572_80360723 | 1.33 |
D330025C20Rik |
RIKEN cDNA D330025C20 gene |
2134 |
0.23 |
chr7_110615016_110615390 | 1.32 |
Sbf2 |
SET binding factor 2 |
281 |
0.89 |
chr8_113847926_113849082 | 1.32 |
Adamts18 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18 |
111 |
0.98 |
chr11_101140208_101140428 | 1.32 |
Gm27626 |
predicted gene, 27626 |
191 |
0.86 |
chr2_27442422_27443138 | 1.32 |
Brd3os |
bromodomain containing 3, opposite strand |
277 |
0.87 |
chrX_96712746_96713886 | 1.32 |
Gpr165 |
G protein-coupled receptor 165 |
125 |
0.98 |
chr13_21408136_21408554 | 1.32 |
Gm50481 |
predicted gene, 50481 |
3706 |
0.09 |
chr6_93911862_93913573 | 1.32 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr10_62338281_62338607 | 1.32 |
Hk1os |
hexokinase 1, opposite strand |
1812 |
0.27 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.3 | 1.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.3 | 3.8 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.2 | 3.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.1 | 5.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.0 | 3.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.9 | 2.8 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.9 | 2.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.9 | 2.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.9 | 2.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.9 | 3.4 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.8 | 5.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.8 | 2.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.8 | 5.8 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.8 | 3.3 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.8 | 2.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 2.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 2.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 2.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.7 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 4.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.7 | 0.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.7 | 3.6 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.7 | 5.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 1.3 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.6 | 1.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 1.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.6 | 1.8 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 1.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.6 | 1.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.6 | 3.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 0.6 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.6 | 1.2 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.6 | 1.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.6 | 2.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.6 | 0.6 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.6 | 2.3 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 1.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 1.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.6 | 2.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.5 | 2.2 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.5 | 1.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.5 | 1.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.5 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 2.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 2.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 0.5 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.5 | 3.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 2.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.5 | 1.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 1.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 1.5 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 2.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 2.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 2.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.5 | 1.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 1.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.5 | 1.0 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.5 | 1.5 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 4.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 2.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 1.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 1.4 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 2.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.5 | 1.8 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 1.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.5 | 0.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.5 | 1.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 2.3 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.5 | 4.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 0.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 3.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 2.7 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.4 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 0.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 0.4 | GO:0006573 | valine metabolic process(GO:0006573) |
0.4 | 1.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.4 | 0.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 0.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 1.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.4 | 1.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.4 | 2.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 1.7 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.4 | 1.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.4 | 0.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.4 | 1.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 1.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 1.2 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.4 | 2.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.4 | 0.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 2.8 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.4 | 0.4 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.4 | 1.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 2.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 1.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.4 | 2.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 2.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.4 | 1.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 1.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.4 | 1.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.4 | 0.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.4 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 0.8 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 0.8 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 0.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.4 | 1.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 0.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 1.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 0.4 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.4 | 1.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 1.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 2.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.4 | 1.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 1.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 1.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 1.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 0.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.4 | 3.5 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.3 | 1.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 1.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 1.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 1.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 1.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 2.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.0 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.3 | 1.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 2.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.3 | 0.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.3 | 1.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.3 | 1.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 2.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 1.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.7 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.3 | 0.3 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.3 | 0.3 | GO:1901321 | positive regulation of heart induction(GO:1901321) |
0.3 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.0 | GO:0030421 | defecation(GO:0030421) |
0.3 | 1.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 1.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 1.3 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 0.3 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.3 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.6 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 1.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.3 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 0.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 0.9 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 2.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 0.6 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 0.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 1.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 0.9 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 2.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 0.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.3 | 1.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.6 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 0.9 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.3 | 2.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 1.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 1.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 0.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 0.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 3.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 0.9 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 0.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.3 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.6 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 0.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 1.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 1.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 1.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 1.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 1.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.3 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 2.4 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.3 | 1.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.3 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 1.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.3 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 1.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.3 | 1.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 2.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.8 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 0.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 0.5 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 1.3 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 1.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 1.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 0.8 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 0.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.3 | 2.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 0.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.3 | 1.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 1.5 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.8 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.5 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.2 | 3.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.7 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.2 | 0.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 1.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 1.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.5 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 1.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 4.8 | GO:0001964 | startle response(GO:0001964) |
0.2 | 1.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 3.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.5 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 1.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 1.9 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 1.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 1.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 2.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 1.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 0.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 1.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 1.6 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.2 | 0.7 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 1.8 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 1.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 2.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 1.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.7 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 0.9 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 1.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 1.1 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 0.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.7 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.9 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 1.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.7 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.2 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.9 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 0.9 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 0.2 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.2 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.4 | GO:0051610 | serotonin uptake(GO:0051610) |
0.2 | 0.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 3.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 1.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.4 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 1.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 1.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.4 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.6 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.6 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 2.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 1.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.4 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.2 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 2.5 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 0.8 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 3.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.6 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.4 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.2 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 1.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 1.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.4 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.2 | 1.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.2 | 2.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.6 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.2 | 0.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 1.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.4 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 2.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.8 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.6 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.8 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 4.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 1.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 2.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.2 | 0.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 0.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.4 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 1.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 1.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.2 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.2 | 1.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.4 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 0.4 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 1.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 1.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 4.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.2 | 0.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 2.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 1.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 0.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 1.1 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.4 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 1.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 1.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 1.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.5 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.2 | 0.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 1.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 4.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.7 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.2 | 0.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 1.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 2.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.4 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.2 | 1.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 0.7 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 0.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 0.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.7 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 1.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 2.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 1.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 1.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 2.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.5 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.2 | 1.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 2.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.2 | 1.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.2 | 0.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 3.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 1.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 1.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 1.4 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.2 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 1.8 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.5 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 0.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 2.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.7 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 1.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.1 | 0.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 1.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.4 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.1 | 1.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.1 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 1.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.7 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 1.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.8 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.6 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.6 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 2.1 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 1.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 1.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.7 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 1.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 1.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.5 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.8 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 2.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.5 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 1.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.5 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.6 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.4 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 2.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 1.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.3 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.5 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.3 | GO:0003174 | mitral valve development(GO:0003174) |
0.1 | 0.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 2.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 1.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.2 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.7 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 1.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.4 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.8 | GO:0009265 | 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.1 | 0.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.7 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 3.0 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.3 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.2 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 1.2 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 1.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 1.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.2 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 1.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.9 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.1 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 2.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 1.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 1.9 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.1 | 1.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.7 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.3 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 1.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 1.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.8 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.1 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 1.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 1.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 1.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 2.6 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 3.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.1 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 1.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.6 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 1.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.7 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 0.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 4.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 1.1 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.4 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.4 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.2 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 4.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 2.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.1 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 0.5 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 1.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.5 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.1 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.4 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.4 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 1.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.7 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 1.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.0 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.3 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.1 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.5 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.1 | 0.9 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 1.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.7 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.2 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 2.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 1.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.2 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 1.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 3.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.1 | 0.4 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.2 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.1 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 1.8 | GO:0006096 | glycolytic process(GO:0006096) |
0.1 | 0.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 1.0 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.3 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 1.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.4 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 1.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.4 | GO:0050802 | circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.4 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.1 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.3 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.2 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.2 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 1.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.8 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.7 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.1 | 0.2 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.3 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.3 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
0.1 | 0.1 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 1.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.1 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 1.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.9 | GO:0032355 | response to estradiol(GO:0032355) |
0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.5 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.3 | GO:0051937 | catecholamine transport(GO:0051937) |
0.0 | 0.4 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.0 | 3.5 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.4 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.1 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.5 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.0 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.0 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 1.1 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 1.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.0 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.3 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 2.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 1.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.4 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.0 | 0.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.0 | 0.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.6 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.4 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.3 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.0 | 0.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.2 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.2 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.0 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.0 | 1.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.0 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 0.6 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 1.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.0 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.0 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.3 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 0.0 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.0 | 0.1 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.0 | 0.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.0 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.1 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.0 | 0.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.0 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.0 | 0.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.0 | 0.0 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.0 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.0 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.0 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:1900042 | regulation of interleukin-2 secretion(GO:1900040) positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.4 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.0 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.7 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 4.0 | GO:0044393 | microspike(GO:0044393) |
0.8 | 2.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.8 | 3.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.7 | 2.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.7 | 2.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.7 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.6 | 0.6 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.6 | 1.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 1.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.5 | 3.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.5 | 2.0 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 2.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 1.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.5 | 5.1 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 1.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 2.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 2.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 1.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 1.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 3.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.5 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 1.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 5.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 0.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 1.7 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 2.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 1.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 1.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 1.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 4.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 0.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 2.4 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 2.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 1.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 4.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 0.8 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 1.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 2.6 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 1.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 0.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 3.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 1.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 1.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 0.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 1.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 1.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 1.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 1.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.2 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 2.5 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.5 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 1.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 6.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 3.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 1.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 3.1 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.8 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 13.4 | GO:0034705 | potassium channel complex(GO:0034705) |
0.2 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 3.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 6.8 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 1.1 | GO:0002177 | manchette(GO:0002177) |
0.2 | 1.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 0.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 2.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 2.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 1.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 2.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 1.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 2.9 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 2.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 3.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 2.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 2.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.8 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 2.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 4.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 2.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 5.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 5.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.2 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 7.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.6 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 1.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 2.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 3.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 2.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 11.7 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 2.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 5.3 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 3.2 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.9 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 7.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 1.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.8 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 4.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 1.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 2.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 3.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 15.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 1.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 1.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 3.3 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 1.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.8 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 1.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 1.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.4 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 2.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.8 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.4 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.1 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 3.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 3.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 19.9 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 2.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 2.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 3.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 2.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 5.5 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 2.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 17.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.5 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 3.0 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 2.9 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.1 | 0.3 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 6.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 2.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.3 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 4.8 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.7 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.4 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 4.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 3.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 1.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 6.4 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 1.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.7 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 1.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 1.6 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 0.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 2.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 15.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.4 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 1.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 2.9 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 3.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 1.9 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 6.9 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 1.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.4 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.7 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 100.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.3 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.0 | GO:0030867 | signal recognition particle receptor complex(GO:0005785) rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.3 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.0 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 1.3 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 9.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.8 | GO:0044297 | cell body(GO:0044297) |
0.0 | 8.4 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 0.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 3.2 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.0 | 0.0 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 2.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 3.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.7 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 2.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 2.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 5.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 4.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 2.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 2.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.6 | 1.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 2.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.6 | 2.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 1.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.5 | 1.5 | GO:0070538 | oleic acid binding(GO:0070538) |
0.5 | 2.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 2.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 1.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 1.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 2.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 1.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 1.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 3.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 2.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 0.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 1.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 3.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 1.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 1.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 5.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 0.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 1.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 1.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 3.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 1.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 2.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 1.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.4 | 1.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 1.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 1.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 2.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 1.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 0.4 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.4 | 1.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 2.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 1.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 0.7 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 1.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 0.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 1.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.4 | 0.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.4 | 1.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.4 | 1.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 7.6 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 3.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 1.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 3.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 0.9 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 1.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 1.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 0.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 7.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 0.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 2.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 4.9 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.3 | 8.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 0.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 2.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 3.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 3.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 0.8 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.3 | 1.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 2.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 0.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 2.3 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 0.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 1.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 3.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 1.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 1.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 1.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.2 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 1.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 2.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.2 | 0.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 3.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 1.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 9.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 2.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 1.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 2.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 7.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 2.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 1.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 2.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 3.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 2.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 3.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 4.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.2 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.4 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 3.1 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 4.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 1.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 1.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 2.5 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 2.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 4.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.7 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 0.7 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.2 | 1.7 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 1.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 3.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 1.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 3.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 1.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.7 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 3.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 2.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 1.0 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 1.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 3.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 1.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 0.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 1.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.8 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 1.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.8 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 3.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.6 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 3.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 3.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 2.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 2.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.7 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.9 | GO:0018647 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 1.0 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 2.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 3.8 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 1.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 12.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 2.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 4.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 2.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 2.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 3.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.0 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 2.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 1.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.4 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.3 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 1.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 2.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 2.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 8.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 1.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 1.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 0.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 1.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.7 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 2.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.9 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 1.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.4 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.6 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 2.8 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 3.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 2.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 3.6 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 1.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 2.1 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.5 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 1.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 4.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 1.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 1.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 2.4 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 1.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.9 | GO:0034885 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 4.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 1.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 2.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 12.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 10.0 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 1.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 7.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.5 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 2.2 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.9 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 3.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 2.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 3.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 1.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.8 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 1.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 5.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 1.2 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 1.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 1.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 1.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.0 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 1.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 1.5 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 1.2 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.2 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 1.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.0 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.6 | GO:0005516 | calmodulin binding(GO:0005516) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 3.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 2.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 5.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 3.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 2.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 4.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 3.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 7.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 2.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 6.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 7.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 5.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 2.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 2.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 0.9 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 5.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 6.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 0.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 2.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 6.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 5.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 4.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 4.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 4.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 2.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 2.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 3.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 3.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 11.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 15.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 9.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 6.3 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 4.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 4.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 5.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 0.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 4.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 4.4 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.3 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 8.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 7.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 2.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 5.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 3.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 3.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 3.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 2.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 3.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 3.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 0.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 5.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 1.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.3 | 6.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 6.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 3.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 4.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 0.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 4.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 5.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 3.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 0.4 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 2.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 1.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 2.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 0.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 2.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 3.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.2 | 1.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 3.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 2.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 3.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 3.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 1.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 1.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 1.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 2.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 3.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 3.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 1.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 2.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 8.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 1.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 3.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 1.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 6.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 3.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 3.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.4 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 1.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 1.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 2.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 3.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 6.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 3.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 2.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 4.9 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 6.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 1.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 1.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |